Latest news

Insights

Top 10 AI Trends Reshaping Precision Medicine

Executive Summary Precision medicine is moving from a largely genomics-driven model toward a broader approach that combines molecular, clinical, imaging,...
Insights

The Economics of Rare Disease Drug Development

Executive Summary Rare disease drug development presents a distinctive economic challenge for pharmaceutical companies. The scientific need can be substantial, but...
Insights

The Economics of Decentralized Clinical Trials

Executive Summary Decentralized clinical trials are changing how pharmaceutical companies think about the economics of clinical research. Traditional trials often require...
Insights

Top 10 Digital Biomarkers Changing Clinical Research

Executive Summary Clinical research is expanding beyond measurements collected during scheduled site visits. Wearables, smartphones, connected medical devices, and digital...
Clinical

MimiVax’s brain cancer vaccine misses phase 2b goal, but CEO sees a path forward in younger patients

MimiVax’s cancer vaccine failed to meet the primary endpoint...
Clinical

Cerevance’s Solengepras Meets Phase 3 Goal in Parkinson’s Disease Trial

Cerevance reported positive topline results from its Phase 3...
Regulatory

FDA Identifies Four Deaths in Newron’s Evenamide Studies as Clinical Hold Continues

Newron Pharmaceuticals said the U.S. Food and Drug Administration (FDA) has identified four deaths among patients treated with its...
Clinical

Zealand’s obesity medication fails once more in phase 3

Boehringer Ingelheim's survodutide drug has achieved the co-primary endpoints in a phase 3 trial in adults with obesity and...
Manufacturing

BD Plans Huge U.S. Investment to Expand Medical Manufacturing

BD is preparing a major expansion of its U.S. operations, adding to a growing list of healthcare companies increasing...
Clinical

Phase 3 Firmonertinib Study Misses Primary Endpoint in EGFR Exon 20 NSCLC

ArriVent BioPharma reported that its phase 3 Furvent trial...
Insights

How Healthcare Organizations Are Building AI Centers of Excellence

   Executive Summary Artificial intelligence is moving from isolated healthcare experiments...
Insights

The Rise of Platform Biotech Companies

Executive Summary Biotechnology companies have traditionally been built around individual drug candidates, therapeutic programs, or specific biological targets. A different model...
Insights

Top 10 Emerging Modalities Beyond RNA Therapeutics

Executive Summary Pharmaceutical innovation is expanding beyond conventional small molecules and established biologics as researchers pursue new ways to address...
Manufacturing

FDA Warns Fresenius Kabi Over Manufacturing Deviations Linked to Famotidine Adverse Event Reports

The U.S. Food and Drug Administration (FDA) has issued a warning letter to Fresenius Kabi after identifying deficiencies in...
Commercial

Life Sciences Voice In Collaboration With Future Pharma EU 2026

Future Pharma Europe returns on 20–21 October 2026 in...
Editorial Team -

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Suki Launches AI Dictation Tool Integrated With Epic and Meditech EHRs

Suki announced Tuesday the release of Suki Dictation, an artificial intelligence-powered dictation solution designed...
Editorial Team -

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

Healthcare-related infections remain a persistent challenge for hospitals, affecting roughly one in every 40...
Editorial Team -

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

The U.S. Food and Drug Administration (FDA) granted Johnson & Johnson De Novo clearance...
Editorial Team -

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Alnylam has entered into a partnership with the scientist instrumental in developing the technology...
Editorial Team -

Regulatory

Regulatory

FDA Identifies Four Deaths in Newron’s Evenamide Studies as Clinical Hold Continues

Newron Pharmaceuticals said the U.S. Food and Drug Administration...
Editorial Team -
Insights

The Economics of Rare Disease Drug Development

Executive Summary Rare disease drug development presents a distinctive economic...
Insights

The Economics of Decentralized Clinical Trials

Executive Summary Decentralized clinical trials are changing how pharmaceutical companies...
Insights

Top 10 Digital Biomarkers Changing Clinical Research

Executive Summary Clinical research is expanding beyond measurements collected during...
Commercial

Theramex purchases Asieris’ innovative cervical lesion treatment for up to $250 million

Asieris, a China-based company, has agreed to pay up...

Research & Development

Market Access

Manufacturing

Genentech signs a $490 million breast cancer partnership and lays off 103 employees with gRED Rethink

The Roche subsidiary has just announced that the restructuring...
Manufacturing

fda selects seven drugmakers for precheck pilot to accelerate u.s. manufacturing reviews

The U.S. Food and Drug Administration (FDA) has selected...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Insights

Top 10 AI Trends Reshaping Precision Medicine

Executive Summary Precision medicine is moving from a largely genomics-driven...
Editorial Team -
Insights

The Economics of Decentralized Clinical Trials

Executive Summary Decentralized clinical trials are changing how pharmaceutical companies...
Editorial Team -